Document is current
Any future updates will be listed below
-
Authors
Shibue, Kimitaka
Kahraman, Sevim https://orcid.org/0000-0002-2880-6589
Castillo-Quan, Jorge Ivan https://orcid.org/0000-0002-6324-2854
De Jesus, Dario F.
Hu, Jiang
Morita, Hiroyuki
Blackwell, T. Keith https://orcid.org/0000-0003-3763-9134
Yi, Peng https://orcid.org/0000-0001-7830-4694
Kulkarni, Rohit N. https://orcid.org/0000-0001-5029-6119
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DK067536, R35GM122610, R01AG054215)
MEXT | Japan Society for the Promotion of Science (JP22K16404)
- License Information
-
More Information
Article History
Received: 7 October 2023
Accepted: 9 September 2025
First Online: 15 October 2025
Competing interests
: R.N.K. serves on the Scientific Advisory Boards of Novo Nordisk, Biomea and REDD Pharmaceuticals. The other authors declare no competing interests.
